Kamalika Mukherjee, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Podocytes | 2 | 2022 | 396 | 0.760 |
Why?
|
| Oxidative Stress | 3 | 2021 | 3086 | 0.750 |
Why?
|
| Protein Carbonylation | 2 | 2020 | 29 | 0.710 |
Why?
|
| Tubulin | 5 | 2020 | 695 | 0.650 |
Why?
|
| Fluorescent Dyes | 6 | 2020 | 1917 | 0.650 |
Why?
|
| Staining and Labeling | 2 | 2013 | 1100 | 0.390 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1972 | 0.340 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2208 | 0.310 |
Why?
|
| Immunotoxins | 1 | 2023 | 179 | 0.220 |
Why?
|
| Dynamins | 1 | 2022 | 152 | 0.200 |
Why?
|
| Taurine | 1 | 2020 | 94 | 0.180 |
Why?
|
| Boron | 1 | 2019 | 36 | 0.170 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2021 | 442 | 0.170 |
Why?
|
| Virus Latency | 1 | 2021 | 358 | 0.160 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2019 | 111 | 0.160 |
Why?
|
| Heterocyclic Compounds | 1 | 2019 | 249 | 0.160 |
Why?
|
| Nitrogen | 1 | 2019 | 344 | 0.160 |
Why?
|
| Hydrazines | 2 | 2015 | 226 | 0.140 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2015 | 22 | 0.140 |
Why?
|
| Proteinuria | 1 | 2019 | 658 | 0.140 |
Why?
|
| Peptide Synthases | 2 | 2013 | 80 | 0.130 |
Why?
|
| Hydrazones | 2 | 2015 | 102 | 0.130 |
Why?
|
| Culture Media, Serum-Free | 1 | 2015 | 158 | 0.130 |
Why?
|
| Cattle | 4 | 2015 | 3922 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 2 | 2015 | 324 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2023 | 1373 | 0.120 |
Why?
|
| Oxidants | 1 | 2015 | 164 | 0.120 |
Why?
|
| Boron Compounds | 1 | 2015 | 178 | 0.120 |
Why?
|
| Microtubules | 3 | 2020 | 1090 | 0.120 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2013 | 91 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 2699 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2077 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2023 | 2149 | 0.100 |
Why?
|
| Polymerization | 1 | 2013 | 164 | 0.100 |
Why?
|
| Tubulin Modulators | 1 | 2012 | 110 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2015 | 731 | 0.100 |
Why?
|
| Benzofurans | 1 | 2011 | 140 | 0.090 |
Why?
|
| Phenylalanine | 1 | 2011 | 365 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5867 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.080 |
Why?
|
| Animals | 10 | 2023 | 168757 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 624 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2010 | 981 | 0.070 |
Why?
|
| Kidney | 1 | 2022 | 7186 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 2538 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 16689 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2011 | 1708 | 0.060 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2023 | 90 | 0.060 |
Why?
|
| HIV-1 | 1 | 2021 | 6939 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2012 | 1972 | 0.050 |
Why?
|
| Tyrosine | 2 | 2020 | 1461 | 0.050 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 127 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 81183 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2021 | 344 | 0.050 |
Why?
|
| Virus Activation | 1 | 2021 | 319 | 0.040 |
Why?
|
| Azides | 1 | 2019 | 116 | 0.040 |
Why?
|
| Fluorescence | 2 | 2013 | 751 | 0.040 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2021 | 371 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2557 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2012 | 1899 | 0.040 |
Why?
|
| DNA | 1 | 2011 | 7301 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 936 | 0.030 |
Why?
|
| Drug Design | 2 | 2012 | 1076 | 0.030 |
Why?
|
| Cyclization | 1 | 2015 | 65 | 0.030 |
Why?
|
| Benzaldehydes | 1 | 2015 | 58 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2012 | 1970 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2021 | 3128 | 0.030 |
Why?
|
| HIV Infections | 1 | 2021 | 16718 | 0.030 |
Why?
|
| Benzoates | 1 | 2015 | 217 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 744343 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 1801 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 313 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1990 | 0.030 |
Why?
|
| Salmon | 1 | 2011 | 36 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2019 | 901 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2012 | 5456 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2011 | 220 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2015 | 965 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2170 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2021 | 3494 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2011 | 624 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2011 | 563 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6386 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 761 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2012 | 730 | 0.020 |
Why?
|
| Brain | 2 | 2013 | 26385 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2011 | 2255 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13695 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2011 | 1454 | 0.020 |
Why?
|
| Insulin | 1 | 2023 | 6580 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2011 | 772 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6473 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2011 | 625 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 2011 | 0.020 |
Why?
|
| Male | 2 | 2022 | 350118 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14557 | 0.010 |
Why?
|
| Female | 1 | 2022 | 380194 | 0.010 |
Why?
|
| Binding Sites | 1 | 2012 | 6114 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5882 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13881 | 0.010 |
Why?
|
| Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 24260 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10481 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 21683 | 0.000 |
Why?
|